Posted by Michael Wonder on 19 Jul 2024
PHARMAC proposes to widen access to urinary tract infections treatment and fund a new epilepsy treatment
18 July 2024 - PHARMAC is consulting on improving access to treatment for urinary tract infections, as well as providing another treatment option for people with some types of epilepsy.
“Our Anti-Infective Advisory Committee has told us that providing the medicine fosfomycin in the community would make a big difference for this group of people. In fact, we think this proposal would reduce the number of people needing to go to the hospital for treatment by 80%, which is an amazing outcome for patients and the health system.”
This consultation also proposes funding zonisamide to treat some forms of epilepsy.
